While Ideaya Biosciences Inc has overperformed by 7.09%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, IDYA fell by -10.62%, with highs and lows ranging from $44.42 to $13.45, whereas the simple moving average fell by -1.61% in the last 200 days.
On June 26, 2025, Wells Fargo started tracking Ideaya Biosciences Inc (NASDAQ: IDYA) recommending Overweight. A report published by Stephens on November 18, 2024, Initiated its previous ‘Overweight’ rating for IDYA. Leerink Partners also Downgraded IDYA shares as ‘Market Perform’, setting a target price of $27 on the company’s shares in a report dated November 05, 2024. UBS Initiated an Buy rating on October 24, 2024, and assigned a price target of $50. Cantor Fitzgerald initiated its ‘Overweight’ rating for IDYA, as published in its report on October 15, 2024. Mizuho’s report from July 08, 2024 suggests a price prediction of $50 for IDYA shares, giving the stock a ‘Outperform’ rating. BTIG Research also rated the stock as ‘Buy’.
Analysis of Ideaya Biosciences Inc (IDYA)
There are several well-rounded types of analysis and research techniques that can be used to gain a clear view of Ideaya Biosciences Inc’s future performance, with equity being one of the most critical indicators. The goal here is to ensure that your current return on equity of -31.34% is sufficient for you to turn a profit off your investment. Taking into account the quick ratio of the company, currently set at 13.92, you can see that the company can cover any debts it may have, which can easily be seen in the annual report of the company.
As an indicator of volatility for any stock, average volume can also be very valuable, and IDYA is recording an average volume of 1.34M. On a monthly basis, the volatility of the stock is set at 4.46%, whereas on a weekly basis, it is put at 4.28%, with a gain of 8.76% over the past seven days. Furthermore, long-term investors anticipate a median target price of $48.00, showing growth from the present price of $22.97, which can serve as yet another indication of whether IDYA is worth investing in or should be passed over.
How Do You Analyze Ideaya Biosciences Inc Shares?
Apart from looking at the fundamentals, you should also pay attention to the number of company employees who own shares. This is because the values should be in line with investors’ expectations. As such, the current holdings of company stock inside the company are set at 10.05%. This can enable you to see the extent to which executives own the company’s stock. As opposed to executive stock, institutional ownership accounts for 106.33% of the company’s shares, contributing to an indication of company value, since large shareholders may signify strength within the organization.
IDYA shares are owned by institutional investors to the tune of 106.33% at present.
